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Background:  Mild  hypothermia  (MH)  decreases  infarct  size  and  mortality  in  experimental  reperfused
myocardial  infarction,  but  may  potentiate  ischaemia-induced  left  ventricular  (LV) diastolic  dysfunction.
Methods:  In  anaesthetized  pigs  (70  ± 2 kg),  polystyrol  microspheres  (45  m) were  infused  repeatedly
into  the  left  circumﬂex  artery  until  cardiac  power  output  decreased  >40%.  Then, pigs  were  assigned  to
normothermia  (NT,  38.0 ◦C, n =  8) or MH  (33.0 ◦C,  n =  8, intravascular  cooling)  and  followed  for  6 h (CME
6  h).  *p <  0.05  vs  baseline,  †p  < 0.05 vs  NT.
Results:  In  NT, cardiac  output  (CO)  decreased  from  6.2  ±  0.3  to  3.4 ± 0.2*  l/min,  and  heart  rate  increased
from  89  ±  4  to 101  ± 6*  bpm.  LV  end-diastolic  volume  fell from  139  ±  8  to 64  ±  4  ml*,  while LV ejection
fraction  remained  constant  (49  ± 1 vs  53  ±  4%). The  corresponding  end-diastolic  pressure–volume  rela-
tionship  was  progressively  shifted  leftwards,  reﬂecting  severe  LV  diastolic  dysfunction.  In MH,  CO  fell
to  a similar  degree.  Spontaneous  bradycardia  compensated  for  slowed  LV  relaxation,  and  the  leftward
shift  of  the  end-diastolic  pressure–volume  relationship  was less  pronounced  during  MH.  MH  increased
systemic  vascular  resistance,  such  that  mean  aortic  pressure  remained  higher  in  MH  vs  NT  (69  ±  2†  vs
54 ± 4 mmHg).  Mixed  venous  oxygen  saturation  at  CME  6  h  was  higher  in MH  than  in  NT  (59  ±  4†  vs
42  ± 2%)  due  to lowered  systemic  oxygen  demand  during  cooling.
Conclusion:  We  conclude  that  (i)  an  acute  loss  of  end-diastolic  LV  compliance  is a major  component  of
acute cardiac  pump  failure  during  experimental  myocardial  infarction,  and  that  (ii) MH  does  not  potenti-
ate this  diastolic  LV  failure,  but  stabilizes  haemodynamics  and  improves  systemic  oxygen  supply/demand
imbalance  by reducing  demand.. Introduction
The induction of mild hypothermia (MH, 32–34 ◦C) after car-
iac arrest improves both neurological outcome and survival1,2 and
as become intensive care guideline therapy.3 There is increasing
vidence that better survival may  in part be related not only to
eurological, but also to direct cardiovascular effects. Myocardial
nfarct size could be reduced by MH when cooling was initiated
Abbreviations: CME, coronary microembolisation; MH,  mild hypothermia; NT,
ormothermia; LV, left ventricular.
 A Spanish translated version of the summary of this article appears as Appendix
n  the ﬁnal online version at http://dx.doi.org/10.1016/j.resuscitation.2012.05.011.
∗ Corresponding author at: Klinische Abt. für Kardiologie, Medizinische Univer-
ität Graz, Auenbruggerplatz 15, 8036 Graz, Austria. Tel.: +43 316 385 80774;
ax: +43 316 385 13733.
E-mail address: heiner.post@medunigraz.at (H. Post).
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before the onset of reperfusion, both in the experimental setting4
and in patients.5 MH  induces a hypometabolic state, allowing for
higher central venous oxygen saturation and better preserved oxy-
gen supply/demand balance at a given reduction of cardiac output
in pigs.6,7 Finally, MH  increased left ventricular (LV) contractility
in normal and resuscitated porcine hearts in vivo, which, how-
ever, occurred at slowed LV relaxation and reduced LV end-diastolic
distensibility.7,8
In a porcine model of reperfused myocardial infarction and
subsequent cardiogenic shock, Götberg et al. reported reduced
mortality and improved systemic haemodynamics in hypother-
mic  vs normothermic animals.6 However, effects of MH on LV
function were not assessed in this study. Such analysis would be
Open access under CC BY-NC-ND license.of particular interest, as myocardial ischaemia and subsequent
infarction per se negatively affect LV diastolic function. In humans,
transient ischaemia induced by pacing in the presence of an
epicardial stenosis increased LV end-diastolic pressure, resulting
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rom both slowed active relaxation and an up- and leftward shift
f the LV end-diastolic pressure–volume relationship.9,10 In rats,
ogs and pigs, permanent coronary artery ligation11,12 or coronary
icroembolisation13 induced an acute leftward shift of the LV end-
iastolic pressure–volume relationship that lasted up to three days
fter the onset of myocardial infarction.12 Similar ﬁndings were
btained in patients during acute myocardial infarction.14,15
MH  could thus critically potentiate LV diastolic dysfunction dur-
ng acute myocardial infarction. We  aimed to characterize in detail
he effect of MH  on LV systolic and diastolic function during acute
yocardial infarction. We  applied coronary microembolisation as
 model of no-reﬂow myocardial infarction, as the no-reﬂow phe-
omenon represents the worst outcome of reperfusion therapy. It
s a strong predictor of short- and long-term mortality,16 and was
herefore expected to generate pronounced diastolic abnormalities.
. Methods
The experimental protocol was approved by the local Bioethics
ommittee of Vienna, Austria (BMWF-66010/0103-II/10b/2009),
nd conforms with the Guide for the Care and Use of Laboratory
nimals published by the US National Institute of Health (NIH Pub-
ication No. 85-23, revised 1996).
An expanded method section is provided in the online
upplement.
.1. Experimental model
19 anaesthetized pigs (70 ± 2 kg) were instrumented with a
wan-Ganz catheter, a right atrial pacing probe, a LV pressure-
onductance catheter, a valvuloplasty catheter (20 ml)  in the
escending aorta, and an intravascular cooling catheter (AccutrolTM
atheter 14F, InnerCool RTx Endovascular System, Philips Health-
are, Vienna, Austria) in the inferior vena cava. Body temperature
as maintained at 38 ◦C by the intravascular device.
.2. Experimental protocol
Blood samples were drawn at baseline conditions, and steady-
tate haemodynamics were acquired at spontaneous heart rate and
uring right atrial pacing at 100, 120, 140, 160, and if possible,
t 180 bpm. Loading conditions were varied by short inﬂation of
he aortic balloon catheter at spontaneous heart rate. Myocardial
nfarction was then induced by coronary microembolisation (CME)
nto the proximal left circumﬂex coronary artery: repetitive slow
1 min) injections of 500,000 polystyrene microspheres (45 m)
ere administered until cardiac power output (W,  mean aortic
ressure × cardiac output/451) was reduced by more than 40%.
hree animals developed sustained ventricular ﬁbrillation during
icrosphere injections and were excluded from subsequent anal-
sis. The remaining pigs were assigned sequentially 1:1 to either
H (n = 8, 33 ◦C) or normothermia (NT, n = 8, 38 ◦C). Measurements
ere repeated immediately (CME 0 h), and at 2 h, 4 h and 6 h after
ME  (CME 2 h, CME  4 h, CME  6 h, respectively). In MH,  cooling was
tarted after the CME  0 h measurement. Animals were sacriﬁced
y an 80 mmol  potassium chloride bolus. Blood gas analyses were
erformed immediately after withdrawal. Troponin T levels were
ssessed in serum obtained at CME  6 h.
.3. Data analysis and statistics
Haemodynamic and conductance data were analysed off-line
y CircLab software (custom made by P. Steendijk). Beyond stan-
ard parameters, we analysed data obtained during varied loading
onditions (linear regression) to assess values for , dP/dtmin  and
he end-systolic volume at an end-systolic pressure of 100 mmHg,n 83 (2012) 1503– 1510
as well as the end-systolic pressure–volume relationship. The
end-diastolic pressure–volume relationship was derived from an
exponential ﬁt of corresponding data points.7
All data are presented as mean ± SEM. Data were ana-
lysed by 1-way or 2-way ANOVA for repeated measurements.
Pressure–volume relationships were compared by analysis of
covariance (ANCOVA). Post hoc testing was performed by Tukey’s
test. A p-value < 0.05 indicated signiﬁcant differences.
3. Results
Three to ﬁve (median 4) microsphere injections were necessary
to decrease cardiac power output by more than 40% according to
the protocol. The total number of injected microspheres was sim-
ilar between groups (NT: 2.1 ± 0.2 million, MH:  2.1 ± 0.1 million;
2.1 million microspheres correspond to a volume of approximately
0.1 ml). After the ﬁnal injection, coronary angiography demon-
strated reduced left circumﬂex coronary artery blood ﬂow (TIMI
1 in all animals) that remained unchanged at the end of the proto-
col. No coronary artery damage was observed. At CME  6 h, levels of
troponin T (ng/ml) were 2.2 ± 0.2 in NT and 2.8 ± 0.7 in MH (p = NS).
3.1. Systemic haemodynamics
In normothermic pigs heart rate increased, while cardiac output
and mean aortic pressure decreased, resulting in a reduced cardiac
power output after CME  (all p < 0.05 vs baseline, Fig. 1A–C). Dur-
ing MH  heart rate decreased (p < 0.05 vs baseline and vs NT). At a
similar cardiac output, an increased systemic vascular resistance
during MH  resulted in a better preserved mean aortic pressure
(both p < 0.05 vs NT, Fig. 1A–C, Table 1). Mean pulmonary arte-
rial pressure increased to a small extent in both groups (p < 0.05
vs baseline, Table 1).
3.2. Blood samples
Mixed venous oxygen saturation decreased progressively after
CME  during NT (p < 0.05 vs baseline and vs CME  0 h, Fig. 1D). With
lower whole body oxygen consumption in MH  (p < 0.05 vs base-
line, Table 1), mixed venous oxygen saturation recovered to near
baseline values (Fig. 1D). The haemoglobin concentration slightly
decreased during normothermia with no signiﬁcant difference
between groups (Table 1).
3.3. LV dimensions
LV end-diastolic, end-systolic and stroke volume decreased after
CME in both groups (p < 0.05 vs baseline, Fig. 2A–C). This decrease
was progressive at CME  6 h in NT (p < 0.05 vs CME  0 h), but not in
MH (p = NS vs CME  0 h). LV ejection fraction remained near baseline
levels throughout the protocol in both groups (Fig. 2D).
3.4. LV systolic function
LV maximum pressure (LVPmax) as well as maximum dP/dt
decreased after CME  in both groups (p < 0.05 vs baseline, Fig. 3A–F,
Table 1); this decrease was progressive in NT (p < 0.05 vs CME 0 h).
LVPmax remained higher during MH  than during NT at CME  6 h
(p < 0.05, Table 1). Pressure–volume analysis did not reﬂect a loss
of LV contractility after CME. In both groups, the slope of the end-
systolic pressure–volume relationship increased, the loops did not
shift rightwards, and the LV end-systolic volume at an end-systolic
pressure of 100 mmHg  remained constant compared to the respec-
tive baseline values (Figs. 3G–I and 4A and B, Table 1).
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Fig. 1. *p < 0.05 vs baseline, †p < 0.05 vs NT, §p < 0.05 vs CME  0 h.
Fig. 2. *p < 0.05 vs baseline, †p < 0.05 vs NT, §p < 0.05 vs CME  0 h.
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Table 1
Haemodynamic and metabolic data.
Baseline CME  0 h CME  2 h CME  4 h CME  6 h
Temp (◦C) NT 38.0 ± 0.0 38.2 ± 0.1 38.1 ± 0.1 38.1 ± 0.0 38.0 ± 0.0
MH  38.0 ± 0.1 38.0 ± 0.2 35.0 ± 0.3*,† ,§ 33.2 ± 0.2*,† ,§ 32.9 ± 0.1*,† ,§
LVPmax (mmHg) NT 119 ± 6 83 ± 3* 79 ± 4* 75 ± 3* 66 ± 4*,§
MH 121 ± 5 88 ± 5* 91 ± 3* 80 ± 2* 79 ± 3*,†
LVPed (mmHg) NT 9.0 ± 0.9 14.7 ± 1.3* 15.5 ± 1.2* 13.5 ± 1.3* 11.4 ± 1.7
MH  7.7 ± 0.6 15.9 ± 1.7* 16.4 ± 1.4* 14.9 ± 1.1* 14.2 ± 0.9*
dP/dtmax (mmHg/s) NT 1819 ± 84 1216 ± 53* 1235 ± 52* 1095 ± 51* 974 ± 67*,§
MH 1777 ± 79 1310 ± 137* 1462 ± 110* 1232 ± 88* 1174 ± 73*
dP/dtmin (mmHg/s) NT −2293 ± 107 −1308 ± 82* −1213 ± 102* −1132 ± 79* −957 ± 84*,§
MH −2317 ± 100 −1348 ± 118* −1005 ± 66*,§ −705 ± 54*,† ,§ −672 ± 72*,† ,§
dP/dtmin−Pes100
(mmHg/s)
NT −2136 ± 76 −1563 ± 50* −1584 ± 63* −1547 ± 47* −1446 ± 42*
MH −2199 ± 94 −1554 ± 81* −1204 ± 54*,† ,§ −978 ± 58*,† ,§ −889 ± 69*,† ,§
 (ms) NT 39 ± 1 43 ± 1 43 ± 2 43 ± 1 43 ± 1
MH  39 ± 1 48 ± 2 74 ± 4*,† ,§ 103 ± 13*,† ,§ 101 ± 8*,† ,§
-Pes100 (ms) NT 34 ± 2 50 ± 2 48 ± 3 50 ± 2 57 ± 2*
MH 30  ± 2 56 ± 4* 74 ± 3*,† ,§ 104 ± 7*,† ,§ 118 ± 12*,† ,§
Slope ESPVR (mmHg/ml) NT 1.6 ± 0.2 2.2 ± 0.3 2.6 ± 0.3* 2.6 ± 0.3* 2.6 ± 0.4*
MH 1.3 ± 0.2 2.1 ± 0.2 2.5 ± 0.4* 2.4 ± 0.3* 2.9 ± 0.4*
Ves-Pes100 (ml) NT 62 ± 7 63 ± 8 50 ± 4 42 ± 5 47 ± 4
MH 76 ±  8 83 ± 8† 77 ± 9† 75 ± 7† 68 ± 7†
SVR (mmHg/l/min) NT 16.2 ± 1.4 15.1 ± 1.0 15.3 ± 0.9 14.7 ± 0.9 13.6 ± 1.1
MH  15.8 ± 0.6 16.6 ± 1.6 19.8 ± 1.6*,† 19.9 ± 1.7*,† 20.2 ± 1.0*,† ,§
CPO (W) NT 1.43 ± 0.10 0.66 ± 0.06* 0.60 ± 0.06* 0.55 ± 0.06* 0.42 ± 0.06*,§
MH 1.55 ± 0.10 0.73 ± 0.06* 0.71 ± 0.05* 0.57 ± 0.06* 0.50 ± 0.03*,§
Mean PAP (mmHg) NT 21 ± 1 23 ± 1 27 ± 1* 26 ± 1* 26 ± 2*
MH 18 ± 1 23 ± 3 25 ± 2* 28 ± 3* 28 ± 2*
Hb (g/dl) NT 10.4 ± 0.2 10.2 ± 0.2 9.8 ± 0.2* 9.8 ± 0.2* 9.6 ± 0.2*,§
MH 10.3 ± 0.3 10.1 ± 0.2 10.2 ± 0.1 10.1 ± 0.2 10.1 ± 0.3
WB-VO2  (ml/min) NT 308 ± 12 298 ± 6 283 ± 7 283 ± 7 272 ± 12
MH 315 ±  15 291 ± 13 233 ± 12*,† ,§ 197 ± 8*,† ,§ 191 ± 8*,† ,§
temp: temperature, LVPmax: maximum LV pressure, LVPed: end-diastolic LV pressure, dP/dtmin-Pes100: dP/dtmin at an end-systolic pressure of 100 mmHg, -Pes100: tau at
an  end-systolic pressure of 100 mmHg, slope ESPVR: slope of the end-systolic pressure–volume relationship (linear regression), Ves-Pes100: LV end-systolic volume at an end-
systolic  pressure of 100 mmHg, SVR: systemic vascular resistance, CPO: cardiac power output, mean PAP: mean pulmonary arterial pressure, Hb: haemoglobin-concentration,
WB-VO2: whole body oxygen consumption.
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† p < 0.05 vs NT.
§ p < 0.05 vs CME  0 h.
.5. LV diastolic function
A decreased dP/dtmin  and increased  demonstrated impaired
ctive relaxation after CME, both at spontaneous pressures and
hen referred to a LV end-systolic pressure of 100 mmHg  (all
 < 0.05 vs baseline, Table 1). MH potentiated these changes
p < 0.05 vs NT).
The end-diastolic pressure–volume relationship was immedi-
tely shifted left- and upwards after CME  in both groups (p < 0.05
s baseline, Figs. 3G–I and 4A and B). This shift was  progressive at
ME 6 h in NT (p < 0.05 vs CME  0 h), but not in MH.
.6. Effects of atrial pacing
With higher heart rates, LV end-diastolic volume decreased. At
p to 140 bpm, this was associated with a proportionate decrease
f LV end-diastolic pressure, such that the data point fell on the cor-
esponding baseline end-diastolic pressure–volume relationship
Fig. 5A and B). At maximum heart rates (pacing at 160 or 180 bpm),
owever, LV end-diastolic pressure increased in spite of smaller
nd-diastolic volumes, suggesting that the diastolic time interval
as too short to allow for complete relaxation (see also online
upplement). This was true also at CME  0 h and 6 h in NT (Fig. 5C and
), while during MH,  this increase occurred at substantially lower
eart rates (Fig. 5F).
Right atrial pacing increased cardiac output at baseline by a
aximum of 2.5 ± 0.3 l/min in NT. This increase was  smaller at
ME  6 h (0.8 ± 0.3 l/min, p < 0.05 vs baseline). A similar change was
een in MH  (baseline 2.4 ± 0.6, CME  6 h: 1.3 ± 0.4 l/min, p = 0.10 vs
aseline, p = 0.41 vs NT), see also online supplement.4. Discussion
4.1. Acute heart failure after coronary microembolisation during
normothermia
Coronary microembolisation (CME) in the normothermic group
caused severe heart failure, as illustrated by reduced cardiac out-
put, mean aortic pressure, and a fall of mixed venous oxygen
saturation – a net parameter of systemic oxygen supply/demand
balance – below 45% at 6 h after CME  (Fig. 1B–D). In contrast to
long-term LV remodelling after myocardial infarction, this was  not
associated with LV dilatation and reduced LV ejection fraction, but
with a progressive and massive fall of LV volumes with no change
in LV ejection fraction (Fig. 2A–D). LV pressure–volume analy-
sis revealed a rapid leftward shift of the underlying end-diastolic
pressure–volume relationship after CME  that further continued to
the end of the protocol at 6 h after CME, leading to a mean reduction
of LV end-diastolic volume by more than 50% (Figs. 2A, 3G–I and 4A).
Such compromised LV ﬁlling could in principal result from right
ventricular dilatation, delayed LV relaxation, increased passive LV
stiffness, or all of them. At only moderately increased mean pul-
monary artery pressures, it is unlikely that LV ﬁlling was restricted
by right ventricular chamber enlargement. To challenge LV relax-
ation, we  performed right atrial pacing to shorten the diastolic time
interval (detailed data are provided in the online supplement). We
suggested that if prolonged active relaxation would limit LV ﬁlling,
then any increase of heart rate would result in an upward and/or
leftward shift of corresponding LV end-diastolic pressure–volume
data points compared to the end-diastolic pressure–volume rela-
tionship at baseline heart rate. As shown in Fig. 5A, C and E, this was
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Fig. 3. Original registration of left ventricular pressure (LVP) vs time, dP/dt vs time, and LV pressure vs LV volume (LVV) in an animal of the NT group. CME  induced a
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(rogressive decrease of maximum LVP and maximum/minimum dP/dt. The LV end
ubstantially lower LV end-diastolic volumes at given end-diastolic pressures.
rue only at maximum heart rates both before and at 6 h after CME,
ut not at moderately increased heart rates of, for example, 120
nd 140 bpm. We  therefore rule out that active relaxation, although
mpaired after CME  (Table 1), is the limiting factor for LV ﬁlling after
ME, but conclude that the LV after CME  demonstrates an acute and
assive loss of compliance. In line with that, the embolized perfu-
ion territory in the present study was clearly recognized by its hard
ig. 4. The end-systolic pressure–volume relationship (ESPVR) was  steeper after CME  in bo
es100) was  not different between time points. The end-diastolic pressure–volume relatio
CME  0 h). This shift was further pronounced at CME  6 h in NT, but not in MH.lic pressure–volume relationship was progressively shifted leftwards, resulting in
and stiff consistency during autopsy, in considerable contrast to the
non-embolized LV regions. Corresponding ﬁndings were obtained
in rat hearts isolated at up to three days after left anterior coronary
artery ligation; a loss of LV compliance led to an approximately
50% decrease of LV end-diastolic volume at a given end-diastolic
pressure and was associated with myocardial swelling, congestion,
haemorrhage and contraction band necrosis in the infarct zone.12
th groups, but LV end-systolic volume at an end-systolic pressure of 100 mmHg (Ves-
nship (EDPVR) was shifted leftwards immediately after coronary microembolisation
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pig. 5. Only pacing at maximum heart rates caused the corresponding end-diastoli
f  the end-diastolic pressure–volume relationship (EDPVR) obtained at spontaneou
.2. Effects of mild hypothermia
As previously reported by Götberg et al.,6 MH  in the present
tudy did not increase cardiac output, yet MH increased mean aortic
ressure by an increase of systemic vascular resistance and sub-
tantially decreased systemic oxygen demand. This hypometabolic
tate during MH  allowed for a re-increase of mixed venous oxygen
aturation to near baseline values, indicating a substantial improve-
ent of systemic oxygen supply/demand imbalance at improved
ortic pressure.
As demonstrated in previous studies,7,8,17 MH substantially
lowed active relaxation, and atrial pacing demonstrated a
educed maximum heart rate in MH.  However, the end-diastolic
ressure–volume data points during right atrial pacing at 100 bpm
ell on the end-diastolic pressure–volume relationship obtained at
he spontaneous heart rate of less than 70 bpm (Fig. 5F). Slowed
V relaxation during MH  did thus not limit LV diastolic ﬁlling at
pontaneous heart rates. Accordingly, atrial pacing at CME  6 h in
H recruited an increase of cardiac output that was not lower thann NT at the same time point.
MH  per se decreased LV compliance in normal porcine
earts,7,8 which can be explained by altered LV visco-elastic
roperties.18 Surprisingly, the leftward shift of the end-diastolicressure–volume points to fall outside of the 95% conﬁdence interval (dashed lines)
t rate. Maximum heart rate during MH was  lower than during NT.
pressure–volume relationship from CME  0 h to CME  6 h in MH
was less than in NT (Fig. 4B); LV end-diastolic and stroke vol-
ume  were better preserved during MH.  The loss of LV compliance
after CME  in the present study resembles the “stone heart” after
untreated cardiac arrest, which results from ATP loss and subse-
quent cardiomyocyte contracture.19,20 Cooling in isolated rat hearts
(28 ◦C)19 and pigs in vivo (33 ◦C)21 delayed the onset of a stone
heart, and a similar effect within the embolized LV territory and
the hypoperfused but viable infarction border zones may  underlie
better preserved LV compliance during MH  in the present study.
MH is known to exert a positive inotropic effect in a variety of
preparations and species (reviewed in Ref.8), however, such evi-
dence is missing in the present study. Instead, the slope of the
end-systolic pressure–volume relationship increased (rather than
decreased) after myocardial infarction per se but was  not different
in MH  vs NT. Also, end-systolic volumes were higher in MH  vs NT
(Fig. 2B). These ﬁndings reﬂect that acute cardiac pump failure in
the present study results not only from acute systolic dysfunction
due to loss of contractile myocardium, but also from an acute and
progressive increase of passive LV stiffness throughout the cardiac
cycle with increased end-systolic and, in particular, end-diastolic
stiffness. The end-systolic pressure–volume relationship alone is
therefore unable to detect the state of heart failure per se, pointing
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o the pivotal role of diastolic LV function in the present study. Of
ote, the relative measure of LV ejection fraction was transiently
ower in MH  in spite of higher stroke volumes, illustrating its insuf-
ciency to detect diastolic abnormalities of LV function.
.3. Clinical implications
In the clinical setting, the LV contractile phenotype at CME
 h represents a therapeutic dilemma. With the massive leftward
hift of the LV end-diastolic pressure–volume relationship, the
V is unable to hold an adequate preload, and volume adminis-
ration would rapidly induce pulmonary oedema. Catecholamines
ould only have a limited effect, as the end-systolic volume is
lready only a small fraction of baseline values thus preventing
ncreases of stroke volume. Even intraaortic balloon counterpul-
ation (IABP) might be rather ineffective, as coronary perfusion
annot be improved in the presence of massive no-reﬂow, and the
mall LV would not be able to increase its stroke volume when
fterload has been decreased by preceeding inﬂation/deﬂation of
he IABP balloon. Given the disappointing clinical results on the
ffect of IABP on mortality in cardiogenic shock,22 it is a tempt-
ng hypothesis that failure of IABP may  relate to no-reﬂow and the
resence of acute diastolic LV failure as demonstrated in this study.
he induction of MH  in turn represents a promising intervention,
s it improves systemic oxygen supply/demand imbalance not by
ncreasing supply, but by reducing demand. As a method of cooling
uring acute cardiac failure, an intravascular device seems particu-
arly appropriate, as it is effective also during hypocirculatory states
ssociated with body surface hypoperfusion, and does not require
olume loading.
.4. Limitations
We did not obtain data on mortality and on the effect of
ewarming. Boyer et al. reported a survival time of 6.8 ± 0.8 h in nor-
othermic dogs after massive coronary embolization which was
xtended more than 3-fold by surface cooling (32 ◦C),23 and similar
ndings were obtained by Götberg et al. in reperfused myocardial
nfarction.6
Cooling healthy pigs to 25 ◦C and subsequent rewarming
nduced troponin release and systolic dysfunction.24 At milder
egrees of hypothermia, however, such adverse effects seemed
o be smaller: dogs cooled to 28–30 ◦C after massive myocardial
nfarction and rewarmed after 5 h even demonstrated a better
reserved cardiac output and mean aortic pressure compared to
ormothermic animals.25
Finally, in patients with a culprit lesion in the left circumﬂex
rtery, the median time from the onset of symptoms to the onset of
ardiogenic shock was only 3.9 h.26 Thus, protective effects of MH
ithin the ﬁrst hours after myocardial infarction as demonstrated
ere are likely to be clinically relevant.
. Conclusion
We demonstrate that a major mechanism of global LV pump
ailure in our model of no-reﬂow myocardial infarction relates to
cute diastolic heart failure, as the LV is progressively unable to
old an adequate preload. MH attenuates this loss of compliance. In
ddition, MH  improves systemic oxygen supply/demand imbalance
t better preserved aortic pressures and may  thus be a treatment
ption for cardiogenic shock.
1
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